migraine
Implementation of a        monthly limit on sumatriptan decreased an HMO's pharmacy costs but did not       significantly alter migraine-related direct medical costs and health care       resource use of patients with migraine.
Implementation of a        monthly limit on sumatriptan decreased an HMO's pharmacy costs but did not       significantly alter migraine-related direct medical costs and health care       resource use of  @OBJECT$   @PREDICAT$   @SUBJECT$ .